Ubs Group Ag Bridge Bio Pharma, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 4,001,800 shares of BBIO stock, worth $140 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,001,800

Previous 4,109,300 2.62%

Holding current value

$140 Million

Previous $105 Million 4.96%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$22.35 - $29.5 $16.8 Million - $22.2 Million	753,062 Added 69.29%	1,839,855 $50.5 Million
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $132,007 - $172,807	-5,521 Reduced 0.51%	1,086,793 $27.7 Million
Q2 2024 Aug 13, 2024	SELL	$23.0 - $31.04 $166,336 - $224,481	-7,232 Reduced 0.66%	1,092,314 $27.7 Million
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $3.12 Million - $4.61 Million	114,036 Added 11.57%	1,099,546 $34 Million
Q4 2023 Feb 09, 2024	BUY	$24.02 - $43.89 $20 Million - $36.6 Million	832,940 Added 545.94%	985,510 $39.8 Million
Q3 2023 Nov 09, 2023	SELL	$16.89 - $35.01 $169,085 - $350,485	-10,011 Reduced 6.16%	152,570 $4.02 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $1.03 Million - $1.4 Million	77,843 Added 91.86%	162,581 $2.8 Million
Q1 2023 May 12, 2023	SELL	$7.17 - $18.55 $1.97 Million - $5.1 Million	-275,140 Reduced 76.45%	84,738 $1.4 Million
Q4 2022 Feb 08, 2023	BUY	$6.74 - $11.52 $2.37 Million - $4.04 Million	351,065 Added 3983.49%	359,878 $2.74 Million
Q3 2022 Nov 10, 2022	SELL	$7.94 - $12.36 $1.69 Million - $2.62 Million	-212,264 Reduced 96.01%	8,813 $88,000
Q2 2022 Aug 10, 2022	SELL	$5.21 - $12.14 $1.15 Million - $2.68 Million	-220,963 Reduced 49.99%	221,077 $2.01 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $2.77 Million - $6.48 Million	377,753 Added 587.6%	442,040 $4.49 Million
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $551,224 - $2.59 Million	-48,438 Reduced 42.97%	64,287 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $4.26 Million - $5.84 Million	90,850 Added 415.31%	112,725 $5.28 Million
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $396,574 - $545,578	8,534 Added 63.97%	21,875 $1.33 Million
Q1 2021 May 12, 2021	SELL	$55.47 - $72.35 $320,450 - $417,965	-5,777 Reduced 30.22%	13,341 $822,000
Q4 2020 Feb 11, 2021	BUY	$38.38 - $71.11 $31,586 - $58,523	823 Added 4.5%	19,118 $1.36 Million
Q3 2020 Nov 12, 2020	SELL	$27.2 - $42.19 $28,532 - $44,257	-1,049 Reduced 5.42%	18,295 $686,000
Q2 2020 Jul 31, 2020	BUY	$22.22 - $35.69 $76,081 - $122,202	3,424 Added 21.51%	19,344 $631,000
Q1 2020 May 01, 2020	SELL	$16.11 - $36.23 $34,169 - $76,843	-2,121 Reduced 11.76%	15,920 $462,000
Q4 2019 Feb 14, 2020	SELL	$17.96 - $46.63 $281,217 - $730,132	-15,658 Reduced 46.46%	18,041 $632,000
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $666,282 - $1.07 Million	33,099 Added 5516.5%	33,699 $723,000
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $16,182 - $16,530	600 New	600 $16,000

Others Institutions Holding BBIO

# of Institutions

321

Shares Held

176M

Call Options Held

13M

Put Options Held

2.48M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.17B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account